Japan, July 20 -- MEDIMMUNE LLC,AMGEN INC has got intellectual property rights for 'TREATMENT OF ASTHMA WITH ANTI-TSLP ANTIBODY.' Other related details are as follows:
Application Number: JP,2024-127900
Category (FI): A61K39/395@U,C07K16/24,A61P11/06
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Aug. 2, 2024
Publication Date: Oct. 23, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
